A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

It is one of several such projects underway to investigate the effects of GLP-1 RAs in people with psychiatric illnesses and addiction. Importantly, said Agarwal, side effects and responses to ...

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

GLP-1 medications can be life-changing for some people, but they're not a fit for everyone. Some patients don't lose as much weight as they’d hoped, and others have trouble staying on the medication ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access challenges and payer coverage trends affecting treatment options.

It demonstrated not only safety and good tolerance but also promising signs of appetite regulation and weight loss, without the side effects commonly seen with GLP-1 drugs. Bariatric Surgery vs. GLP-1 ...

Use of GLP-1 RA might ameliorate some of these negative effects. Using the TriNetX database, Dr Shah and colleagues identified patients with prostate cancer with pre-existing type 2 diabetes who ...